biotencnología

/Tag:biotencnología
­

Zip patent of Bionaturis Group granted in Australia

ZIP Solutions is a biotechnological company devoted to develop and commercialise innovative solutions for industrial and pharmaceutical applications. The company has an in-depth knowledge of the requirements of the human and animal health industry, and offers its proprietary solutions, Zera® and Splittera, as differentiating and highly competitive tools to meet their demanding needs. 

 

These patents are of special relevance for Bionaturis group since Splittera is subject of a worldwide exclusive licensing agreement with a top leading multinational company, for its commercialization in the industrial purification of biological products. The agreement contemplates upfront, milestone-payments and royalties for sales. This agreement is a proof of principle of the usefulness and added value of Splittera for the biopharmaceutical sector, which presents a global expected market figure worth of 236 billion dollars by 2019.
Splittera is part of the technological portfolio of the CDMO division of the biotechnological group, provided by ZIP Solutions, a specialist in industrial bioprocessing.

To read the Relevant Information (only in Spanish) click here.

About Bionaturis

Bionaturis Group offers premium solutions for human and animal health; it comprises four companies (Bionaturis, Biobide, ZIP Solutions, and BNT Pacific) and two subsidiaries (Biobide USA and BNT China Biosciences) in six different locations around the world. Bionaturis lists on the Spanish stock exchange for SMEs (trading code BNT).

 

 

March 8th, 2018|Blog english|Comments Off on Zip patent of Bionaturis Group granted in Australia

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.

CERRAR